10-Year checkup: are silimed breast implants safe and satisfying?
NCT ID NCT03356132
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 632 women who received Silimed breast implants (textured or polyurethane-coated) for augmentation. Researchers will track side effects and satisfaction over 10 years to understand the implants' safety and performance. The goal is to gather real-world data, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 632 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2018
- Expected to finish
-
Dec 2036
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women aged 18 years old or older who have undergone breast augmentation using Silimed® silicone gel-filled breast implants with textured surface or Silimed® silicone gel-filled breast implants with polyurethane foam coated surface.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * provide written informed consent. * female at birth * be 18 years of age or older * have received breast implant(s) for indication of primary or secondary augmentation until 21 days before (including the visit window) * having received a breast implant with a textured surface or a breast implant with a surface coated with Silimed® polyurethane foam * ability to comply with the protocol throughout the follow-up period. Exclusion Criteria: * mammary reconstruction in at least one breast or augmentation after previous reconstruction, * pregnancy informed or breastfeeding at the inclusion moment, * advanced fibrocystic disease at the time of implantation, * neoplasia of any type not yet treated or being treated at the time of implantation, infection in activity not yet treated or being treated at any site at the time of implantation, * reporting or recording of adverse reactions or intolerance to polyurethane or silicone prior to implantation, * immune diseases affecting active connective tissue or (eg, lupus erythematosus, discoid lupus, scleroderma, etc.) at the time of implantation, * signs of inflammation of the breast or implant site at the time of implantation, * Increased risk of immediate postoperative complications due to use of illicit drugs or medications, * Increased risk of immediate post-surgical complications caused by illicit drug use or medication use, * have participated in another clinical study up to 6 months prior to the placement of the implant, * any other condition which, based on the opinion of the investigator or designee, may prevent the provision of informed consent, renders participation in the study is unsafe, compromises adherence to the protocol, complicates the interpretation of data from the study outcome, or otherwise interferes with the achievement of study objectives.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast implant complications are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Perfektua Serviços Médicos Ltda
RECRUITINGNiterói, Rio de Janeiro, 24230-052, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Fewer dialysis sessions: can Twice-Weekly work as well?
- Can a single audio hypnosis session calm exam nerves and boost test scores?